CClinicalTrials.gg
CompletedNCT02811640Updated Nov 18, 2020Results posted

Intra-abdominal Pressure in Peritoneal Dialysis Patients

An observational study in Peritoneal Dialysis, sponsored by Ottawa Hospital Research Institute. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-11-18.

Sponsored by Ottawa Hospital Research Institute · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
12
Ages
18 Years and older
Sex
All
01

Study summary

Patients treated with peritoneal dialysis (PD) are at increased risk of developing mechanical complications such as dialysate leaks and hernias thought to be related to an increase in intra-abdominal pressure (IAP) secondary to the addition of dialysate to the abdomen. Resistance training has been shown to increase IAP but it is unclear in the general population and in patients treated with PD if this training increases the risk of developing hernias.

This study is observing the difference in IAP pressure measurements obtained by the Stryker intracompartmental (STIC) pressure monitor versus the standard IAP pressure measurements obtained with the insufflator at the time of PD catheter insertion.

Read the detailed description

Ten patients who are having a peritoneal dialysis (PD) catheter inserted at the Ottawa Hospital, and who provide informed consent, will undergo intra-abdominal pressure (IAP) measurements with the Stryker intracompartmental (STIC) pressure monitor. Values will be compared to the insufflator at inflation pressures 5,10, and 15 mmHg (millimeters of mercury).

To determine if the Stryker pressure monitor is appropriate for measuring IAP in PD patients, the observed pressures will be analyzed with Bland Altman plots. If the mean difference between readings is 5 mmHg and 95% of the points fall within 2 standard deviations of the mean difference, the Stryker pressure monitor will be considered an acceptable method of measuring IAP.

This tool will then be used as part of a future larger trial which will 1) measure IAP with resistance training in patients treated with PD; with and without dialysate, 2) assess PD patient interest in participating in resistance training trials and 3) determine the appropriateness of the proposed resistance training program for this patient population.

The ultimate goal is to use this study to help inform and develop a clinical trial to 1) assess the impact of resistance training on quality of life and functional status, 2) assess the risk of developing leaks/hernias, and 3) determine if there is an association between IAP during resistance training and subsequent hernia development

02

Conditions studied

  • Peritoneal Dialysis

Keywords

  • Intra-Abdominal Pressure
  • Stryker Pressure Monitor
03

In context

Lead sponsor

Ottawa Hospital Research Institute is the lead sponsor of 538 studies on the registry; 100 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients (>18 years old) with chronic kidney disease that will have a PD catheter inserted in the operating room at the Ottawa Hospital using laparoscopic surgery

Inclusion criteria

  • Adult patients (>18 years old)
  • Chronic kidney disease
  • Will have a PD catheter inserted in the operating room at the Ottawa Hospital using laparoscopic surgery

Exclusion criteria

Exclusion Criteria:

  • Patients who will have a non-standard PD catheter insertion position (eg parasternal)
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
12 participants (actual)
Patient registry
No

Groups and cohorts

  • Study Participants

    Adults with chronic kidney disease who will have a PD catheter inserted at the Ottawa Hospital

    Other: Study Participants

Interventions

  • OtherStudy Participants

    IAP will be observed and measured with a hand held Stryker Pressure Monitor during laparoscopic surgery and compared to the standard IAP measurements obtained with the insufflator at the time of PD catheter insertion

    Also known as: Observation

06

What researchers measure

Primary outcomes

  1. Intra-Abdominal Pressure (IAP)

    The Intra-Abdominal Pressure (IAP) measured with the Stryker monitor connected to the peritoneal dialysis (PD) catheter was compared with the insufflator pressures at of 15, 10, and 5 mm Hg.

    Time frame: During laparoscopic surgery, up to 30 minutes

07

Results

Posted Nov 18, 2020
Limitations and caveats
Technical problems with measurement leading to small sample size, and lack of a gold standard comparative may have affected our results. .

Participant flow

Participant flow — Overall Study
MilestoneStudy Participants
Started12
Completed10
Not completed2
Withdrew: Technology malfunction2

Outcome measures

PrimaryIntra-Abdominal Pressure (IAP)

The Intra-Abdominal Pressure (IAP) measured with the Stryker monitor connected to the peritoneal dialysis (PD) catheter was compared with the insufflator pressures at of 15, 10, and 5 mm Hg.

Time frame:
During laparoscopic surgery, up to 30 minutes
Reported as:
Mean · mm Hg
Intra-Abdominal Pressure (IAP)
mm HgStudy Participants
15 mm Hg-0.5 ± 2.0
10 mm Hg-0.2 ± 3.1
5 mm Hg-1.2 ± 2.6

Adverse events

Collected over During laparoscopic surgery, up to 30 minutes. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Study Participants0/12 (0%)0/12 (0%)0/12 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Study Participants
<=18 years0
Between 18 and 65 years8
>=65 years4
Age, Continuous
Age, Continuous(years)Study Participants
Mean53 ± 15
Sex: Female, Male
Sex: Female, Male(Participants)Study Participants
Female3
Male9
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Study Participants
Region of Enrollment
Region of Enrollment(participants)Study Participants
Canada12
08

Study locations

1 site
  • Ottawa Hospital
    Ottawa, Ontario K1H 7W9, Canada
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jul 25, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02811640
Lead sponsor
Ottawa Hospital Research Institute
Responsible party
Sponsor
First posted
Jun 23, 2016
Start date
Jun 30, 2016
Primary completion
Sep 2017
Completion
Apr 25, 2019
Results posted
Nov 18, 2020
Last update
Nov 18, 2020

Study contacts

Deborah Zimmerman, MD, MSc
principal investigator · Ottawa Hospital Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion